Africa UN Knowledge Hub for COVID-19

The CDC has approved a second COVID-19 booster for people age 50 and older that can be given 4 months after a first booster.

Britain approved Valneva's COVID-19 vaccine on Thursday, becoming the first European country to clear the use of the French firm's shot

COVID-19 vaccine candidates developed by a Sinopharm subsidiary and Sinovac Biotech (SVA.O) to target the Omnicom variant were approved for clinical trials in Hong Kong

The continent followed Western nations too closely in its early response to the coronavirus emergency, says Nigerian virologist Oyewale Tomori.

Pfizer declined to participate in a study involving HIV-infected people and pregnant women and Moderna is balking

Report fanned the flames of controversy over evidence about whether a lab leak or a natural “spillover” of the virus from animals to humans was the most likely source from which the COVID pandemic emerged

The lineages’ rise seems to stem from their ability to infect people who were immune to earlier forms of Omicron and other variants.

Ghana's policy is to create herd immunity by vaccinating at least 20 million out of the current estimated 30.8 million Ghanaians and the first-ever COVID-19 vaccination in the country begun on Tuesday, March 2, 2021, as a measure to curb the further spread of the disease.

South Africa weekly deaths from all causes: 29 Dec 2019 – 6 Aug 2022

Hair loss, reduced sex drive, and erectile dysfunction have joined a list of better-known symptoms linked to long COVID in patients who were not hospitalized, according to findings of a large study.